Literature DB >> 23570892

Reduced serum nerve growth factor in patients with late-life depression.

Breno S Diniz1, Antonio L Teixeira, Rodrigo Machado-Vieira, Leda L Talib, Wagner F Gattaz, Orestes V Forlenza.   

Abstract

INTRODUCTION: Nerve growth factor (NGF) is one of the most abundant neurotrophic factors in the central nervous system and has been involved in several neuropsychiatric disorders.
METHODS: We recruited 77 age- and gender-matched elderly subjects (38 with late-life depression, 17 with previous major depressive episode, and 22 healthy subjects in the comparison group). Serum concentration of NGF was determined by enzyme-linked immunosorbent assay.
RESULTS: NGF levels were significantly reduced in the depressed patients (p = 0.002) as compared with healthy elderly controls. Elderly control subjects with previous depressive episode also showed a significant reduction in NGF levels as compared with controls (p <0.01); NGF levels were similar between patients with current depressive episode and previous depressive episode (p = 0.2).
CONCLUSION: The present findings provide additional evidence to the relevance of reduced neurotrophic support in the pathophysiology of late-life depression. Also, reduced serum NGF level may be a state marker of depression in elderly subjects.
Copyright © 2013 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23570892     DOI: 10.1016/j.jagp.2013.01.014

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  20 in total

1.  Structural Plasticity of the Hippocampus and Amygdala Induced by Electroconvulsive Therapy in Major Depression.

Authors:  Shantanu H Joshi; Randall T Espinoza; Tara Pirnia; Jie Shi; Yalin Wang; Brandon Ayers; Amber Leaver; Roger P Woods; Katherine L Narr
Journal:  Biol Psychiatry       Date:  2015-03-05       Impact factor: 13.382

2.  Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression.

Authors:  Breno S Diniz; Antonio L Teixeira; Rodrigo Machado-Vieira; Leda L Talib; Marcia Radanovic; Wagner F Gattaz; Orestes V Forlenza
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-08-22       Impact factor: 4.077

3.  The effect of gender, age, and symptom severity in late-life depression on the risk of all-cause mortality: the Bambuí Cohort Study of Aging.

Authors:  Breno S Diniz; Charles F Reynolds; Meryl A Butters; Mary Amanda Dew; Josélia O A Firmo; Maria Fernanda Lima-Costa; Erico Castro-Costa
Journal:  Depress Anxiety       Date:  2013-12-18       Impact factor: 6.505

4.  Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress.

Authors:  Thiago W Viola; Saulo G Tractenberg; Mateus Luz Levandowski; Júlio Carlos Pezzi; Moisés Evandro Bauer; Antonio Lúcio Teixeira; Rodrigo Grassi-Oliveira
Journal:  J Psychiatry Neurosci       Date:  2014-05       Impact factor: 6.186

5.  Nerve growth factor sensitizes adult sympathetic neurons to the proinflammatory peptide bradykinin.

Authors:  Oscar Vivas; Martin Kruse; Bertil Hille
Journal:  J Neurosci       Date:  2014-09-03       Impact factor: 6.167

6.  Expression and interaction of TNF-α and VEGF in chronic stress-induced depressive rats.

Authors:  Baohua Li; Bin Wang; Min Chen; Gongying Li; Maosheng Fang; Jinguo Zhai
Journal:  Exp Ther Med       Date:  2015-07-15       Impact factor: 2.447

Review 7.  Parsing the Network Mechanisms of Electroconvulsive Therapy.

Authors:  Amber M Leaver; Randall Espinoza; Benjamin Wade; Katherine L Narr
Journal:  Biol Psychiatry       Date:  2021-11-26       Impact factor: 12.810

8.  Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis.

Authors:  André R Brunoni; Rodrigo Machado-Vieira; Carlos A Zarate; Erica L M Vieira; Leandro Valiengo; Isabela M Benseñor; Paulo A Lotufo; Wagner F Gattaz; Antonio L Teixeira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-08-27       Impact factor: 5.067

9.  Radix Bupleuri ameliorates depression by increasing nerve growth factor and brain-derived neurotrophic factor.

Authors:  Xia Wang; Qing Feng; Yong Xiao; Ping Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

10.  Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review.

Authors:  Yen-Wen Chen; Pao-Yen Lin; Kun-Yu Tu; Yu-Shian Cheng; Ching-Kuan Wu; Ping-Tao Tseng
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-01       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.